Phase 2 data highlights best-in-class potential of dual GLP-1R/GIPR agonist BGM0504 for weight management and metabolic risk reduction in individuals with type 2 diabetes...
- A word from our sponsors -
Newsletter Signup
HomeTagsBH MDE ASA IRN IRQ JDN KWT LBN OM PS QA SDA SYR AE YE CHN ILL UMW USA NAM CLF UWS